这是一个双盲-安慰剂对照-随机-阶乘的临床试验,面神经麻痹患者出现症状72小时内人组。患者被随机分组后接受10天的治疗,一组接受阿昔洛韦,一组接受泼尼松龙,一组同时接受两种药物治疗,另一组接受安慰剂。主要观察指标是面部功能。次要观察指标包括生活质量、外观和疼痛。551例中,496例随机分组。3个月后,P组患者中83.0%面部功能康复,而未接受P治疗的患者中为63.6%(P<0.001)面部功能康复, This is a double-blind-placebo-randomized-factorial clinical trial in which patients with facial nerve palsy develop symptoms within 72 hours of symptom onset. Patients were randomized to receive 10 days of treatment, one receiving acyclovir, one receiving prednisolone, one receiving both drugs and the other receiving placebo. The main observation is the facial features. Secondary indicators include quality of life, appearance and pain. Of the 551 cases, 496 were randomized. Three months later, 83.0% of the patients in group P recovered facial function, compared with 63.6% (P <0.001) in patients who did not receive P,